SciELO - Scientific Electronic Library Online

vol.59 issue6Weight loss and morphometric study of intestinal mucosa in rats after massive intestinal resection: influence of a glutamine-enriched dietPrognostic factors in locally advanced colon cancer treated by extended resection author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links


Revista do Hospital das Clínicas

On-line version ISSN 1678-9903


BERNIK, Márcio; VIEIRA, Antonio Hélio Guerra  and  NUNES, Paula Villela. Bethanecol chloride for treatment of clomipramine-induced orgasmic dysfunction in males. Rev. Hosp. Clin. [online]. 2004, vol.59, n.6, pp.357-360. ISSN 1678-9903.

PURPOSE: To investigate whether bethanecol chloride may be an alternative for the clinical management of clomipramine-induced orgasmic dysfunction, reported to occur in up to 96% of male users. METHODS: In this study, 12 fully remitted panic disorder patients, complaining of severe clomipramine-induced ejaculatory delay, were randomly assigned to either bethanecol chloride tablets (20 mg, as needed) or placebo in a randomized, double-blind, placebo-controlled, two-period crossover study. A visual analog scale was used to assess severity of the orgasmic dysfunction. RESULTS: A clear improvement was observed in the active treatment period. No placebo or carry-over effects were observed. CONCLUSION: These findings suggest that bethanecol chloride given 45 minutes before sexual intercourse may be useful for clomipramine-induced orgasmic dysfunction in males.

Keywords : Orgasmic dysfunction; Clomipramine; Bethanecol chloride; Panic disorder; Pharmacological treatment.

        · abstract in Portuguese     · text in English     · English ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License